MURANO study: exciting times in CLL
How to manage relapsed/refractory MCL - new agents and unmet needs
Understanding the drivers behind disease with the 100,000 Genomes Project
Inherited and acquired genetic factors involved in the development of CLL
John Gribben et al.
How durable are the responses of CLL patients to therapy?